Last update 21 Nov 2024

Anti-CD33/CLL1 CAR-NK(Hangzhou Yingbairui Biomedical )

Overview

Basic Info

Drug Type
CAR-NK
Synonyms-
Target
CD33 x CLL-1
Mechanism
CD33 modulators(Myeloid cell surface antigen CD33 modulators), CLL-1 modulators(C-Type lectin domain family 12 member A modulators)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Acute Myeloid Leukemia
Originator Organization
Yingbairui (Hangzhou) Biomedical Co., Ltd.Yingbairui (Hangzhou) Biomedical Co., Ltd.
Active Organization-
Inactive Organization
Yingbairui (Hangzhou) Biomedical Co., Ltd.Yingbairui (Hangzhou) Biomedical Co., Ltd.
Drug Highest PhasePendingEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Anti-CD33/CLL1 CAR-NK(Hangzhou Yingbairui Biomedical )
NCT05215015 / Unknown statusEarly Phase 1IIT
Clinical Study of Conjugated Antibody Redirecting Natural Killer (CAR-NK) Cells Targeting CD33 and CLL1 in Patients With Acute Myeloid Leukemia
100 Clinical Results associated with Anti-CD33/CLL1 CAR-NK(Hangzhou Yingbairui Biomedical )
Login to view more data
100 Translational Medicine associated with Anti-CD33/CLL1 CAR-NK(Hangzhou Yingbairui Biomedical )
Login to view more data
100 Patents (Medical) associated with Anti-CD33/CLL1 CAR-NK(Hangzhou Yingbairui Biomedical )
Login to view more data
100 Deals associated with Anti-CD33/CLL1 CAR-NK(Hangzhou Yingbairui Biomedical )
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 1
CN
Yingbairui (Hangzhou) Biomedical Co., Ltd.Yingbairui (Hangzhou) Biomedical Co., Ltd.
30 Nov 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free